Top compounds associated with response to S100A13


Feature Type Standardized
Nominal ANOVA
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA alisertib CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.13 0.0003
Download CSV